Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune escape mutations selected by neutralizing antibodies in natural HIV-1 infection can alter coreceptor usage repertoire of the transmitted/founder virus. | Virology | 2022 | 35144109 | PubTator, text mining | PubMed |
| CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory. | Proc Natl Acad Sci U S A | 2022 | 35140181 | PubTator, text mining | PubMed |
| CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma. | Cancer Cell Int | 2022 | 35139863 | PubTator, text mining | PubMed |
| Allogeneic CD20-targeted γδ T cells exhibit innate and adaptive antitumor activities in preclinical B-cell lymphoma models. | Clin Transl Immunology | 2022 | 35136603 | PubTator, text mining | PubMed |
| 4-1BBL-containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells. | Blood Adv | 2022 | 35130345 | PubTator, text mining | PubMed |
| Genetic Alteration, Prognostic and Immunological Role of Acyl-CoA Synthetase Long-Chain Family Member 4 in a Pan-Cancer Analysis. | Front Genet | 2022 | 35126480 | PubTator, text mining | PubMed |
| Systematic evaluation of the prognostic and immunological role of PDLIM2 across 33 cancer types. | Sci Rep | 2022 | 35121770 | PubTator, text mining | PubMed |
| Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation‑resistant pancreatic cancer. | Oncol Rep | 2022 | 35119076 | PubTator, text mining | PubMed |
| Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma. | Comput Math Methods Med | 2022 | 35116071 | PubTator, text mining | PubMed |
| Gelsolin Can Be a Prognostic Biomarker and Correlated with Immune Infiltrates in Gastric Cancer. | Int J Gen Med | 2022 | 35115818 | PubTator, text mining | PubMed |
| T cells and monocytes: A dangerous liaison in adenosine deaminase 2 deficiency. | J Leukoc Biol | 2022 | 35090065 | PubTator, text mining | PubMed |
| Immune function and dysfunction are determined by lymphoid tissue efficacy. | Dis Model Mech | 2022 | 35072206 | PubTator, text mining | PubMed |
| Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma. | J Cancer | 2022 | 35069907 | PubTator, text mining | PubMed |
| Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer. | J Cancer | 2022 | 35069897 | PubTator, text mining | PubMed |
| The Role of Tumor Microenvironment in the Pathogenesis of Sézary Syndrome. | Int J Mol Sci | 2022 | 35055124 | PubTator, text mining | PubMed |
| Challenges and Opportunities for the Translation of Single-Cell RNA Sequencing Technologies to Dermatology. | Life (Basel) | 2022 | 35054460 | PubTator, text mining | PubMed |
| Chemokine CCL18 Promotes Phagocytosis Through Its Receptor CCR8 Rather than PITPNM3 in Human Microglial Cells. | J Interferon Cytokine Res | 2022 | 35041514 | Swiss-Prot, curated | PubMed |
| DOK5 as a Prognostic Biomarker of Gastric Cancer Immunoinvasion: A Bioinformatics Analysis. | Biomed Res Int | 2022 | 35036444 | PubTator, text mining | PubMed |
| Transcriptome analysis of eutopic endometrium in adenomyosis after GnRH agonist treatment. | Reprod Biol Endocrinol | 2022 | 35022045 | PubTator, text mining | PubMed |
| Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration. | Aging (Albany NY) | 2022 | 35017320 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=38